AGP Executive Report
Last update: 10 hours agoBiotech: ImmunityBio says the first European patients have received Anktiva with BCG in Germany and Austria. Its EU approval also covers Liechtenstein. Pharma: Strong European sales of Basilea’s antifungal Cresemba triggered a $37.5 million payment to the Swiss company; the drug is approved in Liechtenstein and other European markets. Liechtenstein–India Tech Links: Talks during Prince Alois’s October visit highlighted cooperation in AI, space, advanced manufacturing and medical technology. Satellite firm Open Cosmos also signaled interest in investing with Indian partners in telecom constellations and Earth observation. EFTA Innovation: A new trade agreement between Vietnam and EFTA, which includes Liechtenstein, is expected to open opportunities for science and technology cooperation and high-tech investment.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.